2026 Suresh S. Ramalingam: Medicine Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Medicine	121	3520	3289	1937	1788	836	104841

Overview

Suresh S. Ramalingam is affiliated with Emory University in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a focus on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research, and Immunology.

Their work encompasses several main topics, including:

Lung Cancer Treatments and Mutations
Cancer Immunotherapy and Biomarkers
Lung Cancer Research Studies
Colorectal Cancer Treatments and Studies
Lung Cancer Diagnosis and Treatment
Cancer Genomics and Diagnostics
Cancer therapeutics and mechanisms

Frequent publication venues for their research include:

Journal of Clinical Oncology (59 publications)
Journal of Thoracic Oncology (44 publications)
Annals of Oncology (20 publications)
Cancer (15 publications)
Cancer Research (12 publications)

Coauthors who have frequently collaborated with Suresh S. Ramalingam are:

Taofeek K. Owonikoko (45 joint publications)
Hossein Borghaei (40 joint publications)
Enriqueta Felip (32 joint publications)
Shi-Yong Sun (26 joint publications)
Madhusmita Behera (26 joint publications)

The following recent papers represent key contributions in the field:

"KRAS ^G12C Inhibition with Sotorasib in Advanced Solid Tumors," New England Journal of Medicine, 2020
"Sotorasib for Lung Cancers with KRAS p.G12C Mutation," New England Journal of Medicine, 2021
"Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial," The Lancet, 2023
"TATTON: a multi-arm, phase Ib trial of osimertinib combined with selumetinib, savolitinib, or durvalumab in EGFR-mutant lung cancer," Annals of Oncology, 2020
"Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer," New England Journal of Medicine, 2023

Best Publications

Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research network

Eric A. Collisson;Joshua D. Campbell;Angela N. Brooks;Angela N. Brooks;Alice H. Berger

5272
Citations
The Immune Landscape of Cancer

Vésteinn Thorsson;David L Gibbs;Scott D Brown;Denise Wolf

4501
Citations
Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

Jean-Charles Soria;Yuichiro Ohe;Johan Vansteenkiste;Thanyanan Reungwetwattana

4403
Citations
Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer.

Tony S. Mok;Yi Long Wu;Myung Ju Ahn;Marina C. Garassino

3279
Citations
Oncogenic Signaling Pathways in The Cancer Genome Atlas

Francisco Sanchez-Vega;Marco Mina;Joshua Armenia;Walid K. Chatila

3193
Citations
Pan-cancer analysis of whole genomes

Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart

3090
Citations
Genomic Classification of Cutaneous Melanoma

Rehan Akbani;Kadir C. Akdemir;B. Arman Aksoy;Monique Albert

3009
Citations
Integrated Genomic Characterization of Papillary Thyroid Carcinoma

Nishant Agrawal;Rehan Akbani;B. Arman Aksoy;Adrian Ally

2825
Citations
Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden

Matthew D. Hellmann;Tudor-Eliade Ciuleanu;Adam Pluzanski;Jong Seok Lee

2822
Citations
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.

Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf

2565
Citations
Comprehensive Characterization of Cancer Driver Genes and Mutations.

Matthew H Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

2512
Citations
Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer.

Matthew D Hellmann;Luis Paz-Ares;Reyes Bernabe Caro;Bogdan Zurawski

2247
Citations
AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer

Pasi A. Jänne;James Chih-Hsin Yang;Dong Wan Kim;David Planchard

2236
Citations
Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC

Suresh S Ramalingam;Johan Vansteenkiste;David Planchard;Byoung Chul Cho

2126
Citations
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma

Benjamin J. Raphael;Ralph H. Hruban;Andrew J. Aguirre;Richard A. Moffitt

1946
Citations
Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial

Naiyer A. Rizvi;Julien Mazières;David Planchard;Thomas E. Stinchcombe

1855
Citations
KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors.

David S. Hong;Marwan G. Fakih;John H. Strickler;Jayesh Desai

1300
Citations
Sotorasib for Lung Cancers with KRAS p.G12C Mutation.

Ferdinandos Skoulidis;Bob T. Li;Grace K. Dy;Timothy J. Price

1166
Citations
Genomic and Functional Approaches to Understanding Cancer Aneuploidy

Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao

1116
Citations
Rescue of exhausted CD8 T cells by PD-1-targeted therapies is CD28-dependent

Alice O. Kamphorst;Andreas Wieland;Tahseen Nasti;Shu Yang;Shu Yang

1034
Citations

Frequent Co-Authors

Taofeek K. Owonikoko Emory University

Fadlo R. Khuri American University of Beirut

Chandra P. Belani Penn State Cancer Institute

Walter J. Curran Emory University

Dong M. Shin Emory University

Shi-Yong Sun Emory University

David R. Gandara University of California, Davis

Pasi A. Jänne Harvard University

Leora Horn Vanderbilt University Medical Center

Matthew D. Hellmann Memorial Sloan Kettering Cancer Center

External Links

Personal website of Suresh S. Ramalingam

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

If you’re considering studying Medicine in the USA, it’s important to explore related online degrees and alternative career pathways in healthcare. The rise of accredited online programs makes it easier than ever to enter the field or expand your qualifications, even while working.

For those interested in health data and administration, pursuing an online mhi can lead to opportunities overseeing health information systems and medical records. If you prefer the fast-growing field of healthcare administration, affordable options for cheapest medical coding certification online will help you master essential billing and coding skills required in hospitals or clinics.

Nursing remains one of the most in-demand career options. Those ready for advanced practice roles can explore accredited online nurse practitioner programs, helping you become a leader in patient care. Alternatively, aspiring nurses can start with entry-level nursing school online, which offers flexible pathways to a rewarding medical career.

These online degrees offer flexibility, affordability, and access to a range of in-demand jobs—helping you find your own place in the rapidly evolving healthcare sector.